Trinity Biotech PLC
TRIB- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000888721
No open-market purchases or sales by Trinity Biotech PLC insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $379.5K in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Trinity Biotech PLC changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 19 | 23 | +4 |
| Shares | 2.68M | 2.61M | −70.8K (−2.6%) |
| Value | $2.95M | $2.30M | −$645.5K (−21.9%) |
New holders (9)
Institutions that held Trinity Biotech PLC at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Raymond James Financial Inc | 26,350 | $23.2K | 0.00% |
| Geode Capital Management, LLC | 17,675 | $15.6K | 0.00% |
| GAMMA Investing LLC | 13,289 | $11.7K | 0.00% |
| Susquehanna International Group, LLP | 12,483 | $11.0K | 0.00% |
| UBS Group AG | 10,621 | $9.35K | 0.00% |
| Clearstead Advisors, LLC | 10,000 | $8.80K | 0.00% |
| Simplex Trading, LLC | 1,432 | $1.00K | 0.00% |
| GWM Advisors LLC | 6 | $5 | 0.00% |
| Transce3nd, LLC | 3 | $3 | 0.00% |
Sold out (5)
Institutions that held Trinity Biotech PLC at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Acadian Asset Management LLC | 41,839 | $46.0K |
| HRT Financial LP | 34,030 | $37.0K |
| Virtu Financial LLC | 17,804 | $20.0K |
| Citadel Advisors LLC | 14,151 | $15.6K |
| SJS Investment Consulting Inc. | 2,000 | $2.20K |